Morning Light Biological: Received the decision document regarding rectification and warning measures from the Xinjiang Securities Regulatory Bureau.

Chenguang Bio announced that the company recently received an administrative regulatory measure decision document issued by the Xinjiang Securities Regulatory Bureau. From March to April 2025, the company borrowed a total of 136 million yuan from its wholly-owned subsidiary, Shengyuan Bio, which constitutes non-operating funds occupation. As a result, the company has been subjected to corrective action, and a warning letter has been issued as part of the supervisory measures, which will be included in the integrity records of the securities and futures market.